Quest Diagnostics benefits from an aging population, driving increased lab testing volumes, and offers 2.0% dividend yield.

The number of bird flu cases has risen to 31 in the U.S. but there is no evidence of person-to-person transmission, the CDC ...

Quest Diagnostics reported strong third-quarter earnings driven by acquisitions, with revenue surpassing expectations, though ...

Lab operator Quest Diagnostics said on Wednesday it will launch a test for H5N1 bird flu at the end of October after the U.S.

Blood tests of several people who were in contact with a patient in Missouri who caught H5N1 bird flu without any known ...

Quest Diagnostics reported strong Q3 earnings, with an 8.5% revenue increase and a 3.6% rise in diluted EPS. Read why I ...

Leerink Partners analyst Michael Cherny has reiterated their neutral stance on DGX stock, giving a Hold rating yesterday. Michael Cherny has ...

Argus raised the firm’s price target on Quest Diagnostics (DGX) to $175 from $163 and keeps a Buy rating on the shares. The company ...

Fintel reports that on October 23, 2024, Baird upgraded their outlook for Quest Diagnostics (NYSE:DGX) from Neutral to ...

The S&P 500 slipped by less than 0.1% on Tuesday, Oct. 22, as the markets digested a mixed bag of corporate earnings reports.

Q3 2024 Earnings Call Transcript October 22, 2024 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...

Quest Diagnostics reports strong Q3 with 8.5% sales growth, raises 2024 revenue guidance to $9.80 billion-$9.85 billion, ...